^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SHR-4602

    i
    Other names: SHR-4602
    Associations

    News

    Trials
    Company:
    Jiangsu Hengrui Pharma
    Drug class:
    HER2-targeted antibody-drug conjugate
    Related drugs:
    Associations

    News

    Trials
    almost1year
    A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors (clinicaltrials.gov)
    P1, N=133, Recruiting, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 mutation • HER-2 expression
    |
    SHR-4602
    1year
    A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors (clinicaltrials.gov)
    P1, N=133, Not yet recruiting, Suzhou Suncadia Biopharmaceuticals Co., Ltd.
    New P1 trial • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 mutation • HER-2 expression
    |
    SHR-4602